Literature DB >> 17448421

Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain.

Niamh Murphy1, Mary Mockler, Mary Ryder, Mark Ledwidge, Ken McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17448421     DOI： 10.1016/j.cardfail.2006.11.006

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  7 in total

1.  Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with postherpetic neuralgia: a case report.

Authors:  Ruth H E De Smedt; Tiny Jaarsma; Stan A J van den Broek; Flora M Haaijer-Ruskamp
Journal:  Br J Clin Pharmacol       Date:  2008-04-10       Impact factor: 4.335

2.  Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice.

Authors:  Mahindra Chincholkar
Journal:  Br J Pain       Date:  2020-03-13

3.  Risk of heart failure and edema associated with the use of pregabalin: a systematic review.

Authors:  Joanne M Ho; Andrea C Tricco; Laure Perrier; Maggie Chen; David N Juurlink; Sharon E Straus
Journal:  Syst Rev       Date:  2013-05-04

4.  Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings.

Authors:  Elisabetta Patorno; Robert J Glynn; Sonia Hernandez-Diaz; Jerry Avorn; Peter M Wahl; Rhonda L Bohn; Daniel Mines; Jun Liu; Sebastian Schneeweiss
Journal:  J Am Heart Assoc       Date:  2013-07-30       Impact factor: 5.501

5.  Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.

Authors:  Yiheng Pan; Pamela B Davis; David C Kaebler; Robert P Blankfield; Rong Xu
Journal:  Cardiovasc Diabetol       Date:  2022-09-01       Impact factor: 8.949

Review 6.  Treatment of postherpetic neuralgia: focus on pregabalin.

Authors:  Kimberly A Cappuzzo
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

7.  Pregabalin in neuropathic pain: evidences and possible mechanisms.

Authors:  Vivek Verma; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.